Correlation Between X4 Pharmaceuticals and Karyopharm Therapeutics
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Karyopharm Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Karyopharm Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Karyopharm Therapeutics, you can compare the effects of market volatilities on X4 Pharmaceuticals and Karyopharm Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Karyopharm Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Karyopharm Therapeutics.
Diversification Opportunities for X4 Pharmaceuticals and Karyopharm Therapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between XFOR and Karyopharm is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Karyopharm Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Karyopharm Therapeutics and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Karyopharm Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Karyopharm Therapeutics has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Karyopharm Therapeutics go up and down completely randomly.
Pair Corralation between X4 Pharmaceuticals and Karyopharm Therapeutics
Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 1.18 times more return on investment than Karyopharm Therapeutics. However, X4 Pharmaceuticals is 1.18 times more volatile than Karyopharm Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Karyopharm Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 129.00 in X4 Pharmaceuticals on August 25, 2024 and sell it today you would lose (95.20) from holding X4 Pharmaceuticals or give up 73.8% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
X4 Pharmaceuticals vs. Karyopharm Therapeutics
Performance |
| Timeline |
| X4 Pharmaceuticals |
| Karyopharm Therapeutics |
X4 Pharmaceuticals and Karyopharm Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with X4 Pharmaceuticals and Karyopharm Therapeutics
The main advantage of trading using opposite X4 Pharmaceuticals and Karyopharm Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Karyopharm Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Karyopharm Therapeutics will offset losses from the drop in Karyopharm Therapeutics' long position.| X4 Pharmaceuticals vs. Eliem Therapeutics | X4 Pharmaceuticals vs. HCW Biologics | X4 Pharmaceuticals vs. RenovoRx | X4 Pharmaceuticals vs. Tempest Therapeutics |
| Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |